A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)

Clinical trial NCT00779584 · COMPLETED

Trial details

NCT number: NCT00779584
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease Lymphoma, Non-Hodgkin Neoplasms

Start date: 2008-10-17
Primary completion: 2011-05-28
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.